METHOD FOR INHIBITING TELOMERASE IN CANCER CELLS BY MEANS OF LUTERION

WIPO Patent Application WO/2016/111530

A1

The present invention relates to a method for inhibiting telomerase in cancer cells by means of luterion and, more particularly, to a method for inhibiting telomerase activity in cancer tissues, cancer cells or a cancer patient, the method in which administered are: an anti-cancer composition containing luterion; a composition for inhibiting telomerase activity in cancer cells; and luterion. Luterion, according to the present invention, has the advantage of effectively inhibiting only the proliferation of cancer cells, without affecting normal cells, by inhibiting telomerase activity in cancer cells.

WO/2006/007712	METHODS COMPRISING POLYETHYLENE GLYCOL-LIPID CONJUGATES FOR DELIVERY OF THERAPEUTIC AGENTS
WO/2000/065076	SYNTHETIC GENE FOR EXPRESSING ACTIVE RETROVIRAL PROTEIN IN EUKARYOTES
JP5848728	Use of PARP activity-inhibiting RNAi in the manufacture of drugs to treat cancer

KWON YOUNG AH (KR)
CHOI WON CHEOL (KR)
JUN HYUN JUNG (US)
CHOI SUK HOON (KR)
CHOI CHANG HOON (KR)
KWON SUNG PIL (KR)

PCT/KR2016/000067

July 14, 2016

January 05, 2016

Click for automatic bibliography generation  

KWON YOUNG AH (KR)

A61K48/00; A61K36/22

WO2012053976A1	2012-04-26
WO2014028763A1	2014-02-20

KR20060132802A

2006-12-22

BURCHETT, K. M. ET AL.: "Telomerase Inhibitor Imetelstat (GRN163L) limits the Lifespan of Human Pancreatic Cancer Cells", PLOS ONE, vol. 9, no. 1, 2014, pages 1 - 15, XP055466582
TICKNER, J. A. ET AL.: "Functions and Therapeutic Roles of Exosomes in Cancer", FRONTIERS IN ONCOLOGY, vol. 4, 2014, pages 1 - 8, XP055156632, DOI: doi:10.3389/fonc.2014.00127
See also references of EP 3243528A4

LEE, Cheo Young et al. (KR)
이처영 (KR)

View/Download PDF      PDF Help

Previous Patent: TWIST HEALTH CYCLE

Next Patent: COOLING DEVICE